Boston Scientific (BSX)

R&D to Revenue

10.22%

Fiscal year · Period ending:

BSX logo

BSX R&D to Revenue

Latest reported10.22%
BSX FY R&D/Revenue (0.00% → 10.22%)
High-resolution chart · PNG

BSX r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
10.2222%
9.6435%
9.9298%
10.4321%
10.1279%
11.5303%
10.9362%
11.3306%
11.019%
10.9707%
11.7159%
11.0705%
12.0538%
12.2224%
11.7423%
12.0292%
12.6038%
12.4099%
13.031%
12.8884%
10.8229%
10.1174%
13.0035%
11.7506%
10.2881%
7.47%
6.9317%
39.4968%
10.5058%
0%
0%
6.5716%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.